Article

Thromboembolic events during neoadjuvant chemotherapy in muscle invasive bladder cancer – any correlation to the central venous access? A clinical practice article

2022-01-13

Abstract excerpt

Patients with muscle invasive bladder cancer have a generally known 5-year overall survival of approximately 58% with neoadjuvant chemotherapy (NAC). During the last decades, addition of Cisplatinum-based NAC in fit patients prior to radical cystectomy (RC), has significantly improved OS, compared to RC only. However, some published studies following NAC addition, describe an intermediate risk increase of thromboe...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 54ada065-c6e0-5a5f-89b1-4dbc18c3cd7a
DOI: 10.12688/f1000research.75922.1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Thromboembolic events during neoadjuvant chemotherapy in muscle invasive bladder cancer – any correlation to the central venous access? A clinical practice articleDOI 10.12688/f1000research.75922.1Read

Consensus statement of the Spanish Society of Internal Medicine and the Spanish Society of Medical Oncology on secondary thromboprophylaxis in patients with cancer.Semantic proximity Read

Adjuvant therapy in breast cancer and venous thromboembolism.Semantic proximity Read

Systemic chemotherapy for patients with bladder cancer--current controversies and future directions.Semantic proximity Read

Incidence, risk factors, and outcome of advanced NSCLC patients receiving antiangiogenic therapy with thromboembolic events: a retrospective cohort studySemantic proximity Read

Risk stratification of in-hospital VTE associated with urinary cancerSemantic proximity Read

Management of Non-Muscle-invasive Bladder Cancer: Quality of Clinical Practice Guidelines and Variations in RecommendationsSemantic proximity Read

How safe are bladder lateral wall tumors?Semantic proximity Read

Immune Checkpoint Inhibitors and Car-T Cell Therapy: Thrombotic and Vascular ComplicationsSemantic proximity Read

Application of Machine Learning to the Prediction of Cancer-Associated Venous ThromboembolismSemantic proximity Read

Potential influence of anaesthesia techniques on the recurrence and progression after resection of nonmuscle invasive bladder cancer: a propensity score-matched analysisSemantic proximity Read

Analysis of thromboembolic events in head and neck cancer patients who underwent concurrent chemoradiotherapy with cisplatin: A real-world studySemantic proximity Read

Incidence and Risk Factors for Postoperative Venous Thromboembolism in Patients with Endometrial Cancer: Systematic Review and Meta-analysisSemantic proximity Read